G567-0259 Screening compound: N~1~-(4-CHLOROBENZYL)-2-[(2-OXO-3-PHENYL-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL)SULFANYL]ACETAMIDE

G567-0259 Screening compound: N~1~-(4-CHLOROBENZYL)-2-[(2-OXO-3-PHENYL-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL)SULFANYL]ACETAMIDE
G567-0259 Screening compound: N~1~-(4-CHLOROBENZYL)-2-[(2-OXO-3-PHENYL-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL)SULFANYL]ACETAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound G567-0259
N~1~-(4-CHLOROBENZYL)-2-[(2-OXO-3-PHENYL-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL)SULFANYL]ACETAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G567-0259

Molecular Formula

C25H19ClN4O2S (C25 H19 ClN4 O2 S)

Compound Name

N~1~-(4-CHLOROBENZYL)-2-[(2-OXO-3-PHENYL-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL)SULFANYL]ACETAMIDE

IUPAC name

n/a

SMILES

O=C(CSC(N1C2c3ccccc3)=Nc(cccc3)c3C1=NC2=O)NCc(cc1)ccc1Cl

InChI

InChI=1S/C25H19ClN4O2S/c26-18-12-10-16(11-13-18)14-27-21(31)15-33-25-28-20-9-5-4-8-19(20)23-29-24(32)22(30(23)25)17-6-2-1-3-7-17/h1-13,22H,14-15H2,(H,27,31)/t22-/m1/s1

InChI Key

YTEMAGPBMPIMMA-JOCHJYFZSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

474.97

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.994

Distribution Coefficient, logD

3.990

Water Solubility, LogSw

-4.69

Polar Surface Area

59.671

Acid Dissociation Constant (pKa)

9.60

Base Dissociation Constant (pKb)

4.71

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

12.00

G567-0259 in Drug Discovery

Included in Screening Libraries

GABA Library (7115 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G567-0259 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G567-0259?
Check Price and Availability of G567-0259, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G567-0259 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G567-0259
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G567-0259
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G567-0259 available by request